Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Class A and Class B Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income/(Loss)	Accumulated Deficit	Non- Controlling Interest
Balances beginning ( in shares) at Dec. 31, 2021		585,878
Balance beginning at Dec. 31, 2021	$ 592,923	$ 58	$ 1,568,638	$ 62	$ (983,941)	$ 8,106
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		6,356
Issuance of common stock upon exercise of stock options	15,653	$ 1	15,652
Issuance of common stock in connection with the acquisition of a business (in shares)		385
Issuance of common stock from acquisition of a business	10,138		10,138
Issuance of common stock under Employee Stock Purchase Plan (in shares)		335
Issuance of common stock under Employee Stock Purchase Plan	14,243		14,243
Vesting of restricted stock units (in shares)		3,616
Withholding taxes related to net share settlement of restricted stock units (in shares)		(3)
Withholding taxes related to net share settlement of restricted stock units	(150)		(150)
Stock-based compensation expense	258,683		258,683
Other (in shares)		55
Other comprehensive income/(loss)	857			346		511
Net loss	(340,754)				(336,642)	(4,112)
Balance ending (Shares) at Jun. 30, 2022		596,622
Balance ending at Jun. 30, 2022	551,593	$ 59	1,867,204	408	(1,320,583)	4,505
Balances beginning ( in shares) at Mar. 31, 2022		592,196
Balance beginning at Mar. 31, 2022	567,461	$ 59	1,705,201	(30)	(1,144,143)	6,374
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		2,206
Issuance of common stock upon exercise of stock options	5,477		5,477
Issuance of common stock in connection with the acquisition of a business (in shares)		385
Issuance of common stock from acquisition of a business	10,138		10,138
Vesting of restricted stock units (in shares)		1,808
Stock-based compensation expense	146,388		146,388
Other (in shares)		27
Other comprehensive income/(loss)	863			438		425
Net loss	(178,734)				(176,440)	(2,294)
Balance ending (Shares) at Jun. 30, 2022		596,622
Balance ending at Jun. 30, 2022	$ 551,593	$ 59	1,867,204	408	(1,320,583)	4,505
Balances beginning ( in shares) at Dec. 31, 2022	604,674	604,674
Balance beginning at Dec. 31, 2022	$ 305,035	$ 59	2,213,603	671	(1,908,307)	(991)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	4,571	4,571
Issuance of common stock upon exercise of stock options	$ 11,140	$ 1	11,139
Issuance of common stock under Employee Stock Purchase Plan (in shares)		639
Issuance of common stock under Employee Stock Purchase Plan	19,921		19,921
Vesting of restricted stock units (in shares)		6,417
Stock-based compensation expense	397,266		397,266
Other comprehensive income/(loss)	(14,373)			(14,766)		393
Net loss	$ (554,789)				(551,090)	(3,699)
Balance ending (Shares) at Jun. 30, 2023	616,301	616,301
Balance ending at Jun. 30, 2023	$ 164,200	$ 60	2,641,929	(14,095)	(2,459,397)	(4,297)
Balances beginning ( in shares) at Mar. 31, 2023		610,487
Balance beginning at Mar. 31, 2023	245,182	$ 60	2,424,340	62	(2,176,620)	(2,660)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		2,308
Issuance of common stock upon exercise of stock options	5,227		5,227
Vesting of restricted stock units (in shares)		3,506
Stock-based compensation expense	212,362		212,362
Other comprehensive income/(loss)	(13,730)			(14,157)		427
Net loss	$ (284,841)				(282,777)	(2,064)
Balance ending (Shares) at Jun. 30, 2023	616,301	616,301
Balance ending at Jun. 30, 2023	$ 164,200	$ 60	$ 2,641,929	$ (14,095)	$ (2,459,397)	$ (4,297)